Advertisement

Tobacco Use in Patients with HIV

  • Jonathan ShuterEmail author
  • Andrea H. Weinberger
Chapter

Abstract

Tobacco use, mainly in the form of cigarette smoking, is hyper-prevalent among persons living with HIV (PLWH). In the early days of the epidemic, smoking received little attention because most patients succumbed to their disease before tobacco-related morbidities could manifest themselves. In the HAART era, patients are surviving longer with their HIV but are suffering from tobacco-related morbidity and mortality at alarming rates. Smoking is associated with a wide range of HIV-related and HIV-unrelated disease processes. Today’s HIV-infected community as a whole loses more years to tobacco use than to the virus itself.

This chapter reviews the history, pathophysiology, epidemiology, behavioral bases, and treatment of tobacco use in PLWH.

Keywords

HIV AIDS Tobacco Cigarette Smoking Treatment 

References

  1. 1.
    United States Public Health Service. Smoking and Health: Report of the advisory committee to the Surgeon General of the Public Health Service. Public Health Service publication 1103. January 1964.Google Scholar
  2. 2.
    United States Public Health Service. The Health Consequences of Smoking: 1968 Supplement to the 1967 Public Health Service Review. Public Health Service publication 1696. 1968.Google Scholar
  3. 3.
    Garrett BE, Dube SR, Trosclair A, Caraballo RS, Pechacek TF, Centers for Disease C, et al. Cigarette smoking – United States, 1965-2008. MMWR Suppl. 2011;60(1):109–13.PubMedGoogle Scholar
  4. 4.
    Hu SS, Neff L, Agaku IT, Cox S, Day HR, Holder-Hayes E, et al. Tobacco Product Use Among Adults – United States, 2013-2014. MMWR Morb Mortal Wkly Rep. 2016;65(27):685–91.PubMedCrossRefGoogle Scholar
  5. 5.
    Mdodo R, Frazier EL, Dube SR, Mattson CL, Sutton MY, Brooks JT, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(5):335–44.PubMedCrossRefGoogle Scholar
  6. 6.
    Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. 2013;56(5):727–34.PubMedCrossRefGoogle Scholar
  7. 7.
    Marcus JL, Chao CR, Leyden WA, Xu L, Quesenberry CP Jr, Klein DB, et al. Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care. J Acquir Immune Defic Syndr. 2016;73(1):39–46.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Schechter MT, Boyko WJ, Jeffries E, Willoughby B, Nitz R, Constance P, et al. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells. Can Med Assoc J. 1985;133(4):286–92.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Newell GR, Mansell PW, Wilson MB, Lynch HK, Spitz MR, Hersh EM. Risk factor analysis among men referred for possible acquired immune deficiency syndrome. Prev Med. 1985;14(1):81–91.PubMedCrossRefGoogle Scholar
  10. 10.
    Burns DN, Kramer A, Yellin F, Fuchs D, Wachter H, DiGioia RA, et al. Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection? J Acquir Immune Defic Syndr. 1991;4(1):76–83.PubMedCrossRefGoogle Scholar
  11. 11.
    Royce RA, Winkelstein W Jr. HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men's Health Study. AIDS. 1990;4(4):327–33.PubMedCrossRefGoogle Scholar
  12. 12.
    Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987;317(4):185–91.PubMedCrossRefGoogle Scholar
  13. 13.
    Swango PA, Kleinman DV, Konzelman JL. HIV and periodontal health. A study of military personnel with HIV. J Am Dent Assoc. 1991;122(7):49–54.PubMedCrossRefGoogle Scholar
  14. 14.
    Syrjanen S, Valle SL, Antonen J, Suni J, Saxinger C, Krohn K, et al. Oral candidal infection as a sign of HIV infection in homosexual men. Oral Surg Oral Med Oral Pathol. 1988;65(1):36–40.PubMedCrossRefGoogle Scholar
  15. 15.
    Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med. 1995;333(13):845–51.PubMedCrossRefGoogle Scholar
  16. 16.
    Mitchell DM, Fleming J, Pinching AJ, Harris JR, Moss FM, Veale D, et al. Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis. 1992;146(3):745–51.PubMedCrossRefGoogle Scholar
  17. 17.
    Galai N, Park LP, Wesch J, Visscher B, Riddler S, Margolick JB. Effect of smoking on the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14(5):451–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Chaisson RE. Smoking cessation in patients with HIV. JAMA. 1994;272(7):564.PubMedCrossRefGoogle Scholar
  19. 19.
    Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000;31(3):808–12.PubMedCrossRefGoogle Scholar
  20. 20.
    Fiore MC, Jaen CR, Baker TB, et al. United States Public Health Service. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD.Google Scholar
  21. 21.
    Burns DN, Hillman D, Neaton JD, Sherer R, Mitchell T, Capps L, et al. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(4):374–83.PubMedCrossRefGoogle Scholar
  22. 22.
    Moorman AC, Holmberg SD, Marlowe SI, Von Bargen JC, Yangco BG, Palella FJ, et al. Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS). Ann Epidemiol. 1999;9(6):349–57.PubMedCrossRefGoogle Scholar
  23. 23.
    Miguez-Burbano MJ, Burbano X, Ashkin D, Pitchenik A, Allan R, Pineda L, et al. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol. 2003;8(1):39–43.PubMedCrossRefGoogle Scholar
  24. 24.
    Marcus JL, Baxter R, Leyden WA, Muthulingam D, Yee A, Horberg MA, et al. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System. AIDS Patient Care STDs. 2016;30(10):463–70.PubMedCrossRefGoogle Scholar
  25. 25.
    Palacio H, Hilton JF, Canchola AJ, Greenspan D. Effect of cigarette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14(4):338–42.PubMedCrossRefGoogle Scholar
  26. 26.
    Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008;10(4):731–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health. 2006;96(6):1060–5.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Rossouw TM, Anderson R, Feldman C. Impact of HIV infection and smoking on lung immunity and related disorders. Eur Respir J. 2015;46(6):1781–95.PubMedCrossRefGoogle Scholar
  29. 29.
    Alpagot T, Duzgunes N, Wolff LF, Lee A. Risk factors for periodontitis in HIV patients. J Periodontal Res. 2004;39(3):149–57.PubMedCrossRefGoogle Scholar
  30. 30.
    Haigentz M Jr. Aerodigestive cancers in HIV infection. Curr Opin Oncol. 2005;17(5):474–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Chin KM, Sidhu JS, Janssen RS, Weber JT. Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients. Obstet Gynecol. 1998;92(1):83–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Klein RS, Ho GY, Vermund SH, Fleming I, Burk RD. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis. 1994;170(6):1404–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Wieland U, Hellmich M, Wetendorf J, Potthoff A, Hofler D, Swoboda J, et al. Smoking and anal high-risk human papillomavirus DNA loads in HIV-positive men who have sex with men. Int J Med Microbiol. 2015;305(7):689–96.PubMedCrossRefGoogle Scholar
  34. 34.
    Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, et al. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis. 2003;36(4):482–90.PubMedCrossRefGoogle Scholar
  35. 35.
    Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Fleischer N, Lo Y, et al. Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis. 2005;40(10):1492–9.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Ryom L, Mocroft A, Kirk O, Ross M, Reiss P, Fux CA, et al. Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons. AIDS. 2014;28(2):187–99.PubMedCrossRefGoogle Scholar
  37. 37.
    Zyambo CM, Willig JH, Cropsey KL, Carson AP, Wilson C, Tamhane AR, et al. Factors Associated With Smoking Status among HIV-Positive Patients in Routine Clinical Care. J AIDS Clin Res. 2015;6(7):480.Google Scholar
  38. 38.
    Allavena C, Guimard T, Billaud E, De la Tullaye S, Reliquet V, Pineau S, et al. Prevalence and Risk Factors of Sleep Disturbance in a Large HIV-Infected Adult Population. AIDS Behav. 2016;20(2):339–44.PubMedCrossRefGoogle Scholar
  39. 39.
    Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, Weissman S, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med. 2005;20(12):1142–5.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TR, et al. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health. 2010;100(10):1896–903.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Friis-Moller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993–2003.PubMedCrossRefGoogle Scholar
  42. 42.
    Kelly SG, Plankey M, Post WS, Li X, Stall R, Jacobson LP, et al. Associations between Tobacco, Alcohol, and Drug Use with Coronary Artery Plaque among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study. PLoS One. 2016;11(1):e0147822.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614–22.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Paisible AL, Chang CC, So-Armah KA, Butt AA, Leaf DA, Budoff M, et al. HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. J Acquir Immune Defic Syndr. 2015;68(2):209–16.PubMedCrossRefGoogle Scholar
  45. 45.
    D'Ascenzo F, Quadri G, Cerrato E, Calcagno A, Omede P, Grosso Marra W, et al. A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era. J Cardiovasc Med (Hagerstown). 2015;16(12):839–43.CrossRefGoogle Scholar
  46. 46.
    Mateen FJ, Post WS, Sacktor N, Abraham AG, Becker JT, Smith BR, et al. Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men. Neurology. 2013;81(24):2094–102.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Knudsen A, Malmberg CA, Kjaer A, Lebech AM. Low prevalence of peripheral arterial disease in a cross-sectional study of Danish HIV-infected patients. Infect Dis (Lond). 2015;47(11):776–82.CrossRefGoogle Scholar
  48. 48.
    Sharma A, Holman S, Pitts R, Minkoff HL, Dehovitz JA, Lazar J. Peripheral arterial disease in HIV-infected and uninfected women. HIV Med. 2007;8(8):555–60.PubMedCrossRefGoogle Scholar
  49. 49.
    Gill MJ, Costagliola D. Editorial commentary: Myocardial infarction in HIV-infected persons: time to focus on the silent elephant in the room? Clin Infect Dis. 2015;60(9):1424–5.PubMedGoogle Scholar
  50. 50.
    d'Ettorre G, Ceccarelli G, Pavone P, Vittozzi P, De Girolamo G, Schietroma I, et al. What happens to cardiovascular system behind the undetectable level of HIV viremia? AIDS Res Ther. 2016;13:21.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Stein JH, Hsue PY. Inflammation, immune activation, and CVD risk in individuals with HIV infection. JAMA. 2012;308(4):405–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Subramanian S, Tawakol A, Burdo TH, Abbara S, Wei J, Vijayakumar J, et al. Arterial inflammation in patients with HIV. JAMA. 2012;308(4):379–86.PubMedPubMedCentralCrossRefGoogle Scholar
  53. 53.
    Bastard JP, Fellahi S, Couffignal C, Raffi F, Gras G, Hardel L, et al. Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity. J Antimicrob Chemother. 2015;70(6):1816–24.PubMedGoogle Scholar
  54. 54.
    Kooij KW, Wit FW, Booiman T, van der Valk M, Schim van der Loeff MF, Kootstra NA, et al. Cigarette smoking and inflammation, monocyte activation and coagulation in HIV-infected individuals on antiretroviral therapy compared to uninfected individuals. J Infect Dis. 2016;214(12):1817–21.Google Scholar
  55. 55.
    Valiathan R, Miguez MJ, Patel B, Arheart KL, Asthana D. Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study. PLoS One. 2014;9(5):e97698.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Benjamin JL, Hedin CR, Koutsoumpas A, Ng SC, McCarthy NE, Prescott NJ, et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis. 2012;18(6):1092–100.PubMedCrossRefGoogle Scholar
  57. 57.
    Lupia E, Bosco O, Goffi A, Poletto C, Locatelli S, Spatola T, et al. Thrombopoietin contributes to enhanced platelet activation in cigarette smokers. Atherosclerosis. 2010;210(1):314–9.PubMedCrossRefGoogle Scholar
  58. 58.
    Gilbert JM, Fitch KV, Grinspoon SK. HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial. Top Antivir Med. 2015;23(4):146–9.PubMedGoogle Scholar
  59. 59.
    Agaku IT, King BA, Husten CG, Bunnell R, Ambrose BK, Hu SS, Holder-Hayes E, Day HR. Tobacco product use among adults – United States, 2012-2013. Morbitity and Mortality Weeky Report. 2014;63(25):542–7.Google Scholar
  60. 60.
    Asma S, Mackay J, Song SY, Zhao L, Morton J, Palipudi KM, Bettcher D, Bhatti L, Caixeta R, Chandora R, Dias RC, da Costa e Silva VL, Fouad H, Hsia J, Husain MJ, McAfee T, Ramanandraibe N, Rarick J, Sinha D, Talley B, d’Espaignet ET, GATS Collaborative Group. The GATS Atlas. 2015. Atlanta, GA: CDC Foundation; 2015.Google Scholar
  61. 61.
    Park LS, Hernandez-Ramirez RU, Silverberg MJ, Crothers K, Dubrow R. Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis. AIDS. 2016;30(2):273–91.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Ledgerwood DM, Yskes R. Smoking Cessation for People Living With HIV/AIDS: A Literature Review and Synthesis. Nicotine Tob Res. 2016;18(12):2177–84.Google Scholar
  63. 63.
    APA. Diagnostic and statistical manual of mental disorders. 5th ed. (DSM-V). Washington, DC: American Psychiatric Association; 2013.Google Scholar
  64. 64.
    Pomerleau OF, Pomerleau CS, Mehringer AM, Snedecor SM, Ninowski R, Sen A. Nicotine dependence, depression, and gender: Characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain. Nicotine Tob Res. 2005;7(1):91–102.PubMedCrossRefGoogle Scholar
  65. 65.
    Sienkiewicz-Jarosz H, Zatorski P, Baranowska A, Ryglewicz D, Bienkowski P. Predictors of smoking abstinence after first-ever ischemic stroke: A 3-month follow-up. Stroke. 2009;40(7):2592–3.PubMedCrossRefGoogle Scholar
  66. 66.
    Pacek LR, Harrell PT, Martins SS. Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals. Am J Addict. 2014;23:582–90.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Benard A, Bonnet F, Tessier JF, Fossoux H, Dupon M, Mercie P, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDs. 2007;21(7):458–68.PubMedCrossRefGoogle Scholar
  68. 68.
    Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. Am J Health Behav. 2012;36(1):75–85.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Gritz ER, Vidrine DJ, Lazev AB, Amick BC 3rd, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6(1):71–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS & Behavior. 2010;14(4):824–35.CrossRefGoogle Scholar
  71. 71.
    McQueen A, Shacham E, Summer W, Overton ET. Beliefs, experience, and interest in pharmacotherapy among smokers with HIV. Am J Health Behav. 2014;38(2):284–96.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Pacek LR, Latkin C, Crum RM, Stuart EA, Knowlton AR. Interest in quitting and lifetime quit attempts among smokers living with HIV infection. Drug Alcohol Depend. 2014;138:220–4.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Hughes JR, Helzer JE, Lindberg SA. Prevalence of DSM/ICD-defined nicotine dependence. Drug Alcohol Depend. 2006;85:91–102.PubMedCrossRefGoogle Scholar
  74. 74.
    Tami-Maury I, Vidrine DJ, Fletcher FE, Danysh H, Arduino R, Gritz ER. Poly-tobacco use among HIV-positive smokers: implications for smoking cessation efforts. Nicotine Tob Res. 2013;15(12):2100–6.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Zyambo CM, Willig JH, Cropsey KL, Carson AP, Wilson C, Tamhane AR, Westfall AO, Burkholder GA. Factors Associated With Smoking Status among HIV-Positive Patients in Routine Clinical Care. Journal of AIDS and Clinical Research. 2015;6:7.CrossRefGoogle Scholar
  76. 76.
    Stewart DW, Jones GN, Minor KS. Smoking, depression, and gender in low-income African Americans with HIV/AIDS. Behav Med. 2011;37(3):77–80.PubMedCrossRefGoogle Scholar
  77. 77.
    Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med. 2007;30(5):371–83.PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Shirley DK, Kesari RK, Glesby MJ. Factors associated with smoking in HIV-infected patients and potential barriers to cessation. AIDS Patient Care STDs. 2013;27(11):604–12.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Akhtar-Khaleel WZ, Cook RL, Shoptaw S, Surkan P, Stall R, Beyth RJ, Teplin LA, Plankey M. Trends and predictors of cigarette smoking among HIV seropositive and seronegative men: The multicenter aids cohort study. AIDS Behav. 2016;20(3):622–32.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7(4):511–22.PubMedCrossRefGoogle Scholar
  81. 81.
    Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United States. J Acquir Immune Defic Syndr. 2006;42:298–306.PubMedCrossRefGoogle Scholar
  82. 82.
    Parhami I, Fong TW, Siani A, Carlotti C, Khanlou H. Documentation of Psychiatric Disorders and Related Factors in a Large Sample Population of HIV-Positive Patients in California. AIDS Behav. 2013;17(8):2792–801.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatr. 2001;158:725–30.PubMedCrossRefGoogle Scholar
  84. 84.
    Stanton CA, Moadel AB, Kim RS, Weinberger AH, Shuter J. Loneliness in HIV-infected smokers. AIDS Care. 2015;27(2):268–72.PubMedCrossRefGoogle Scholar
  85. 85.
    Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the US population. Tob Control. 2014;23:e147–e53.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Weinberger AH, Kashan RS, Shpigel DM, Esan H, Taha F, Lee CJ, Funk AP, Goodwin RD. Depression and cigarette smoking behavior: a critical review of population-based studies. Am J Drug Alcohol Abuse. 2016; [Epub ahead of print];  https://doi.org/10.3109/00952990.2016.1171327.
  87. 87.
    Pacek LR, Latkin C, Crum RM, Stuart EA, Knowlton AR. Current cigarette smoking among HIV-positive current and former drug users: associations with individual and social characteristics. AIDS & Behavior. 2014;18(7):1368–77.CrossRefGoogle Scholar
  88. 88.
    Weinberger AH, Funk AP, Goodwin RD. A review of epidemiologic research on smoking behavior among persons with alcohol and illicit substance use disorders. Prev Med. 2016;  https://doi.org/10.1016/j.ypmed.2016.05.011. [Epub ahead of print].
  89. 89.
    Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Betancourt RM, Stein M, Tashima K, Morrow K, Niaura R. HIV-positive smokers considering quitting: differences by race/ethnicity. Am J Health Behav. 2008;32(1):3–12.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Shuter J, Moadel AB, Kim RS, Weinberger AH, Stanton CA. Self-efficacy to quit in HIV-infected smokers. Nicotine Tob Res. 2014;16(11):1527–31.PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Baker TB, Brandon TH, Chassin L. Motivational influences on cigarette smoking. Annu Rev Psychol. 2004;55:463–91.PubMedCrossRefGoogle Scholar
  92. 92.
    Brandon TH, Baker TB. The Smoking Consequences Questionnaire: The subjective expected utility of smoking in college students. Psychol Assess. 1991;3:484–91.CrossRefGoogle Scholar
  93. 93.
    Peretti-Watel P, Garelik D, Baron G, Spire B, Ravaud P, Duval X, et al. Smoking motivations and quitting motivations among HIV-infected smokers. Antivir Ther. 2009;14(6):781–7.PubMedCrossRefGoogle Scholar
  94. 94.
    Reynolds NR, Neidig JL, Wewers ME. Illness representation and smoking behavior: A focus group study of HIV-positive men. J Assoc Nurses AIDS Care. 2004;15(4):37–47.PubMedCrossRefGoogle Scholar
  95. 95.
    Grover KW, Gonzalez A, Zvolensky MJ. HIV symptom distress and smoking outcome expectancies among HIV+ smokers: A pilot test. AIDS Patient Care STDs. 2013;27(1):17–21.PubMedCrossRefGoogle Scholar
  96. 96.
    Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDs. 2002;16(1):39–42.PubMedCrossRefGoogle Scholar
  97. 97.
    Shapiro AE, Tshabangu N, Golub JE, Martinson NA. Intention to quit smoking among human immunodeficiency virus infected adults in Johannesburg, South Africa. Int J Tuberc Lung Dis. 2011;15(1):140–2.PubMedPubMedCentralGoogle Scholar
  98. 98.
    Shuter J, Salmo LN, Shuter AD, Nivasch EC, Fazzari M, Moadel AB. Provider beliefs and practices relating to tobacco use in patients living with HIV/AIDS: a national survey. AIDS Behav. 2012;16(2):288–94.PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    Keith A, Dong Y, Shuter J, Himelhoch S. Behavioral Interventions for Tobacco Use in HIV-Infected Smokers: A Meta-Analysis. J Acquir Immune Defic Syndr. 2016;72(5):527–33.PubMedGoogle Scholar
  100. 100.
    Pool ER, Dogar O, Lindsay RP, Weatherburn P, Siddiqi K. Interventions for tobacco use cessation in people living with HIV and AIDS. Cochrane Database Syst Rev. 2016;6:CD011120.Google Scholar
  101. 101.
    Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Shadel WG, Stein M, Tashima K, et al. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction. 2009;104(11):1891–900.PubMedPubMedCentralCrossRefGoogle Scholar
  102. 102.
    Stanton CA, Papandonatos GD, Shuter J, Bicki A, Lloyd-Richardson EE, de Dios MA, et al. Outcomes of a Tailored Intervention for Cigarette Smoking Cessation Among Latinos Living With HIV/AIDS. Nicotine Tob Res. 2015;17(8):975–82.PubMedPubMedCentralCrossRefGoogle Scholar
  103. 103.
    Pedrol-Clotet E, Deig-Comerma E, Ribell-Bachs M, Vidal-Castell I, Garcia-Rodriguez P, Soler A. Bupropion use for smoking cessation in HIV-infected patients receiving antiretroviral therapy. Enferm Infecc Microbiol Clin. 2006;24(8):509–11.PubMedCrossRefGoogle Scholar
  104. 104.
    Cui Q, Robinson L, Elston D, Smaill F, Cohen J, Quan C, et al. Safety and tolerability of varenicline tartrate (Champix((R))/Chantix((R))) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care STDs. 2012;26(1):12–9.PubMedPubMedCentralCrossRefGoogle Scholar
  105. 105.
    Ferketich AK, Diaz P, Browning KK, Lu B, Koletar SL, Reynolds NR, et al. Safety of varenicline among smokers enrolled in the lung HIV study. Nicotine Tob Res. 2013;15(1):247–54.PubMedCrossRefGoogle Scholar
  106. 106.
    Tseng TY, Krebs P, Schoenthaler A, Wong S, Sherman S, Gonzalez M, et al. Combining Text Messaging and Telephone Counseling to Increase Varenicline Adherence and Smoking Abstinence Among Cigarette Smokers Living with HIV: A Randomized Controlled Study. AIDS Behav. 2017;21(7):1964–74.Google Scholar
  107. 107.
    Elzi L, Spoerl D, Voggensperger J, Nicca D, Simcock M, Bucher HC, et al. A smoking cessation programme in HIV-infected individuals: a pilot study. Antivir Ther. 2006;11(6):787–95.PubMedGoogle Scholar
  108. 108.
    Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS. 2006;20(2):253–60.PubMedCrossRefGoogle Scholar
  109. 109.
    Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009;13(3):545–54.PubMedCrossRefGoogle Scholar
  110. 110.
    Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012;61(2):208–15.PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106–10.PubMedCrossRefGoogle Scholar
  112. 112.
    Gritz ER, Danysh HE, Fletcher FE, Tami-Maury I, Fingeret MC, King RM, et al. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clin Infect Dis. 2013;57(4):608–15.PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Humfleet GL, Hall SM, Delucchi KL, Dilley JW. A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine Tob Res. 2013;15(8):1436–45.PubMedPubMedCentralCrossRefGoogle Scholar
  114. 114.
    Shuter J, Morales DA, Considine-Dunn SE, An LC, Stanton CA. Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2014;67(1):59–66.PubMedPubMedCentralCrossRefGoogle Scholar
  115. 115.
    Manuel JK, Lum PJ, Hengl NS, Sorensen JL. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care. 2013;25(7):820–7.PubMedCrossRefGoogle Scholar
  116. 116.
    Shelley D, Tseng TY, Gonzalez M, Krebs P, Wong S, Furberg R, et al. Correlates of Adherence to Varenicline Among HIV+ Smokers. Nicotine Tob Res. 2015;17(8):968–74.PubMedPubMedCentralCrossRefGoogle Scholar
  117. 117.
    Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS Care. 2000;11(6):37–44.PubMedCrossRefGoogle Scholar
  118. 118.
    Cropsey KL, Hendricks PS, Jardin B, Clark CB, Katiyar N, Willig J, et al. A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav. 2013;38(10):2541–6.PubMedPubMedCentralCrossRefGoogle Scholar
  119. 119.
    Vidrine DJ, Kypriotakis G, Li L, Arduino RC, Fletcher FE, Tami-Maury I, et al. Mediators of a smoking cessation intervention for persons living with HIV/AIDS. Drug Alcohol Depend. 2015;147:76–80.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of MedicineMontefiore Medical Center and the Albert Einstein College of MedicineBronxUSA
  2. 2.Department of Epidemiology and Population HealthAlbert Einstein College of MedicineBronxUSA
  3. 3.Ferkauf Graduate School of PsychologyYeshiva UniversityBronxUSA

Personalised recommendations